- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4164 - 1,3-Diazoles
Patent holdings for IPC class A61K 31/4164
Total number of patents in this class: 2427
10-year publication summary
|
170
|
183
|
162
|
211
|
219
|
196
|
219
|
193
|
120
|
38
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
34 |
| The Regents of the University of California | 18943 |
23 |
| Lupin Inc. | 85 |
22 |
| F. Hoffmann-La Roche AG | 7958 |
18 |
| Bristol-myers Squibb Company | 5080 |
17 |
| Pharnext | 106 |
17 |
| Centre National de La Recherche Scientifique | 9632 |
15 |
| University of Tennessee Research Foundation | 727 |
15 |
| FUJIFILM Corporation | 27102 |
14 |
| Cedars-Sinai Medical Center | 1088 |
14 |
| Novartis AG | 11238 |
13 |
| The Cleveland Clinic Foundation | 1591 |
13 |
| The Regents of the University of Michigan | 4409 |
12 |
| Enanta Pharmaceuticals, Inc. | 420 |
12 |
| Janssen Pharmaceutica N.V. | 3839 |
11 |
| Abbvie Inc. | 1808 |
11 |
| Galderma Research & Development | 440 |
11 |
| Journey Medical Corporation | 93 |
11 |
| Probiodrug AG | 76 |
11 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
11 |
| Other owners | 2122 |